 sequenc taxol cisplatin phase studi solid tumor patient sequenc taxol cisplatin sequenti dose escal agent taxol dose cisplatin dose dosag permut grade neutropenia cours neutropenia brief hospit neutropenia fever cours escal taxol grade neutropenia cours taxol-cisplatin dose level mean neutrophil count nadir hospit neutropenia fever cours sequenc cisplatin taxol antitumor activ vitro profound altern sequenc pharmacolog studi differ due taxol clearanc rate cisplatin taxol neurotox seriou effect combin modest neurotox patient advers effect myalgia alopecia diarrhea bradycardia asymptomat ventricular tachycardia object respons melanoma non-small-cel lung ovarian breast head neck colon pancreat carcinoma result sequenc taxol cisplatin dose phase ii/iii trial escal taxol treatment